525 related articles for article (PubMed ID: 26527606)
21. Development of Valsartan Floating Matrix Tablets Using Low Density Polypropylene Foam Powder: In vitro and In vivo Evaluation.
Rahamathulla M; Saisivam S; Gangadharappa HV
AAPS PharmSciTech; 2019 Jan; 20(1):35. PubMed ID: 30604045
[TBL] [Abstract][Full Text] [Related]
22. Gastroretentive pulsatile release tablets of lercanidipine HCl: development, statistical optimization, and in vitro and in vivo evaluation.
Reddy GS; Nayak UY; Deshpande PB; Mutalik S
ScientificWorldJournal; 2014; 2014():421931. PubMed ID: 25525619
[TBL] [Abstract][Full Text] [Related]
23. Development of sustained release gastro-retentive tablet formulation of nicardipine hydrochloride using quality by design (QbD) approach.
Chudiwal VS; Shahi S; Chudiwal S
Drug Dev Ind Pharm; 2018 May; 44(5):787-799. PubMed ID: 29198152
[TBL] [Abstract][Full Text] [Related]
24. Physiological relevant in vitro evaluation of polymer coats for gastroretentive floating tablets.
Eisenächer F; Garbacz G; Mäder K
Eur J Pharm Biopharm; 2014 Nov; 88(3):778-86. PubMed ID: 25086221
[TBL] [Abstract][Full Text] [Related]
25. Development of novel bilayer gastroretentive tablets based on hydrophobic polymers.
Nguyen TT; Hwang KM; Kim SH; Park ES
Int J Pharm; 2020 Jan; 574():118865. PubMed ID: 31765783
[TBL] [Abstract][Full Text] [Related]
26. Preformulation studies and optimization of sodium alginate based floating drug delivery system for eradication of Helicobacter pylori.
Diós P; Nagy S; Pál S; Pernecker T; Kocsis B; Budán F; Horváth I; Szigeti K; Bölcskei K; Máthé D; Dévay A
Eur J Pharm Biopharm; 2015 Oct; 96():196-206. PubMed ID: 26247118
[TBL] [Abstract][Full Text] [Related]
27. Influence of water-soluble polymers on the in vitro performance of floating mucoadhesive tablets containing metformin.
Rajab M; Jouma M; Neubert RH; Dittgen M
Drug Dev Ind Pharm; 2014 Jul; 40(7):879-85. PubMed ID: 23607725
[TBL] [Abstract][Full Text] [Related]
28. Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers.
Reddy AB; Reddy ND
Drug Res (Stuttg); 2017 Jul; 67(7):412-418. PubMed ID: 28449156
[TBL] [Abstract][Full Text] [Related]
29. Design and optimization of gastric floating sustained-release mini-tablets of alfuzosin hydrochloride based on a factorial design: in vitro/in vivo evaluation.
Gong L; Yu M; Sun Y; Gao Y; An T; Zou M; Cheng G
Drug Dev Ind Pharm; 2018 Dec; 44(12):1990-1999. PubMed ID: 30058391
[TBL] [Abstract][Full Text] [Related]
30. Effect of formulation parameters on the drug release and floating properties of gastric floating two-layer tablets with acetylsalicylic acid.
Hasçiçek C; Yüksel-Tilkan G; Türkmen B; Ozdemir N
Acta Pharm; 2011 Sep; 61(3):303-12. PubMed ID: 21945909
[TBL] [Abstract][Full Text] [Related]
31. Effect of different polymers and their combinations on the release of metoclopramide HCl from sustained-release hydrophilic matrix tablets.
Savaşer A; Taş Ç; Bayrak Z; Özkan CK; Özkan Y
Pharm Dev Technol; 2013; 18(5):1122-30. PubMed ID: 22881478
[TBL] [Abstract][Full Text] [Related]
32. Controlled release of MT-1207 using a novel gastroretentive bilayer system comprised of hydrophilic and hydrophobic polymers.
Vrettos NN; Wang P; Wang Y; Roberts CJ; Xu J; Yao H; Zhu Z
Pharm Dev Technol; 2023 Oct; 28(8):724-742. PubMed ID: 37493413
[TBL] [Abstract][Full Text] [Related]
33. Risk-based approach for systematic development of gastroretentive drug delivery system.
Mirani AG; Patankar SP; Kadam VJ
Drug Deliv Transl Res; 2016 Oct; 6(5):579-96. PubMed ID: 27468861
[TBL] [Abstract][Full Text] [Related]
34. Study the effect of formulation variables on drug release from hydrophilic matrix tablets of milnacipran and prediction of in-vivo plasma profile.
Singhvi G; Shah A; Yadav N; Saha RN
Pharm Dev Technol; 2014 Sep; 19(6):708-16. PubMed ID: 23931031
[TBL] [Abstract][Full Text] [Related]
35. Design and statistical optimization of an effervescent floating drug delivery system of theophylline using response surface methodology.
Srikanth Meka V; Ee Li C; Sheshala R
Acta Pharm; 2016 Mar; 66(1):35-51. PubMed ID: 26959542
[TBL] [Abstract][Full Text] [Related]
36. Formulation and evaluation of floating tablet of H2-receptor antagonist.
Kesarla RS; Vora PA; Sridhar BK; Patel G; Omri A
Drug Dev Ind Pharm; 2015; 41(9):1499-511. PubMed ID: 25243639
[TBL] [Abstract][Full Text] [Related]
37. Development and Evaluation of a Once-Daily Controlled Porosity Osmotic Pump of Tapentadol Hydrochloride.
Thakkar HP; Pancholi N; Patel CV
AAPS PharmSciTech; 2016 Oct; 17(5):1248-60. PubMed ID: 26677859
[TBL] [Abstract][Full Text] [Related]
38. Polymers derived from Xanthomonas campesteris and Cyamopsis tetragonolobus used as retardant materials for the formulation of sustained release floating matrix tablet of atenolol.
Dey S; Mazumder B; Chattopadhyay S; Das MK; Sinha S; Ganguly S; De K; Mishra M
Int J Biol Macromol; 2014 Apr; 65():346-56. PubMed ID: 24472506
[TBL] [Abstract][Full Text] [Related]
39. Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin.
Chavanpatil MD; Jain P; Chaudhari S; Shear R; Vavia PR
Int J Pharm; 2006 Jun; 316(1-2):86-92. PubMed ID: 16567072
[TBL] [Abstract][Full Text] [Related]
40. Badam gum: a natural polymer in mucoadhesive drug delivery. Design, optimization, and biopharmaceutical evaluation of badam gum-based metoprolol succinate buccoadhesive tablets.
Mylangam CK; Beeravelli S; Medikonda J; Pidaparthi JS; Kolapalli VR
Drug Deliv; 2016; 23(1):195-206. PubMed ID: 24825493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
